Search the Newsreel

Curbline Properties director Alexander Otto sells $5.2m stock

Alexander Otto, a director at Curbline Properties Corp. (NYSE:CURB), sold a total of 231,943 common shares over two trading days, August 12 and 13, 2026. The sales were executed via his affiliated entity, KG Cura Vermogensverwaltung G.m.b.H. & Co., at weighted average prices of …

Napco Security Technologies (NSSC) Leans On Recurring Revenue, Is It Still Below Fair Value?

Palantir-Powered Digital Twin Might Change The Case For Investing In Mercury Systems (MRCY)

Maxim Group Maintains Moleculin Biotech(MBRX.US) With Buy Rating, Cuts Target Price to $2

Maxim Group has reiterated its Buy rating for Moleculin Biotech (MBRX.US) but has reduced the target price for the stock to $2. This adjustment reflects a revised outlook on the company's valuation while maintaining a positive long-term perspective.

Q2 2026 Ocugen Inc Earnings Call Transcript

Ocugen Inc. (OCGN) reported its Q2 2026 earnings, detailing both positive developments like FDA clearance for its Phase 3 trial for OCU410 and extended cash runway into 2028, and negative aspects such as a wider net loss and increased operating expenses. The company is …

DOCU Stock On Track For Fourth Straight Loss – Analyst Says Double-Digit Growth Remains A ‘Long-Term Aspiration’

how InvestingPro’s fair value predicted 56% drop in Indo Thai Securities By Investing.com

Acumen Pharmaceuticals Inc (ABOS) Stock News Today

Q1 2026 ICU Medical Inc Earnings Call Transcript

This article provides the edited transcript of ICU Medical Inc.'s Q1 2026 earnings call, which took place on May 7, 2026. The call began with an introduction from an unidentifiable speaker, followed by Thompson from ICR who welcomed participants to discuss the financial results. …

Recursion Pharmaceuticals (RXRX) Stock Dropped, So What Is Behind The Move?

Palash Securities files Q1FY27 standalone and consolidated results

Marcus & Millichap (MMI) After Its Profit Return And Dividend Why Valuation Still Looks In Focus

Marcus & Millichap (MMI) has returned to profit, completed a multi-year share buyback, and declared a new dividend, drawing investor attention. Despite these positive developments, the company's current share price of $31.58 is considered overvalued compared to its fair value estimate of $28.00. The …

Mill Capital Management LLC Acquires New Position in Cummins Inc. $CMI

Mill Capital Management LLC has acquired a new stake in Cummins Inc. (NYSE:CMI), purchasing 1,665 shares valued at approximately $1.19 million during the second quarter. This move comes as Cummins reported quarterly revenue of $9.46 billion, exceeding estimates, but missed EPS forecasts. The company …

Summit Global Investments Makes New Investment in Customers Bancorp, Inc $CUBI

Walleye Capital LLC Takes Position in Curtiss-Wright Corporation $CW

Walleye Capital LLC has acquired a new stake of 4,412 shares in Curtiss-Wright Corporation, valued at approximately $3.34 million. This move is part of broader institutional interest, with several other funds also adjusting their positions in the aerospace company. Curtiss-Wright recently exceeded quarterly earnings …

Napco Security Technologies (NSSC) Stock Could Be 20% Overvalued On Cash Flow Growth Assumptions

A Discounted Cash Flow (DCF) analysis by Simply Wall St suggests that Napco Security Technologies (NSSC) might be overvalued by approximately 20.4%, with shares trading at $38.32 against an intrinsic value of $31.84. The stock's current P/E ratio of 37.1x also indicates it's priced …

CLEAR Secure, Inc. $YOU Shares Sold by Bank of America Corp DE

Bank of America Corp DE reduced its stake in CLEAR Secure, Inc. by 15.9% in Q1 2026, selling 137,309 shares and retaining 728,052 shares valued at $35.2 million. Other institutional investors also adjusted their positions, with overall institutional ownership at 73.8%. The company reported …

Accuracy Shipping files Q1FY27 results via newspaper ad

Assenagon Asset Management S.A. Buys New Position in AtriCure, Inc. $ATRC

Assenagon Asset Management S.A. has initiated a new position in AtriCure, Inc. (NASDAQ:ATRC), purchasing 62,334 shares valued at approximately $1.74 million. This move comes as AtriCure reported strong quarterly earnings, exceeding revenue estimates with $153.6 million and achieving an EPS of $0.18. Despite positive …

AirSculpt Technologies (NASDAQ:AIRS) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded AirSculpt Technologies (NASDAQ:AIRS) from a "buy" to a "hold" rating, following the company's recent miss on quarterly earnings and revenue expectations. AirSculpt reported $0.01 EPS against an expected $0.02 and $42.9 million in revenue versus $44.14 million anticipated. Despite …

Should Arcutis Biotherapeutics’ (ARQT) Strong Q2 and Higher 2026 Sales Outlook Prompt Investor Action?

Celcuity (NASDAQ:CELC) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Celcuity (NASDAQ:CELC) from a "sell" to a "strong sell," despite a "Moderate Buy" consensus from other analysts with an average price target of $153.64. The company's shares opened at $92, below its 52-week high, and reported a larger-than-expected quarterly loss …

Curtiss-Wright (NYSE:CW) Stock Rating Lowered by Wall Street Zen

Acushnet (NYSE:GOLF) Upgraded at Wall Street Zen

Wall Street Zen has upgraded Acushnet (NYSE:GOLF) from a "hold" to a "buy" rating, despite the broader analyst consensus remaining "Hold" with an average price target of $99.17. The upgrade follows stronger-than-expected quarterly results, where Acushnet reported EPS of $2.08 against an expected $1.63 …

Abacus global CEO Jay Jackson sells $1.7m in company stock By Investing.com

Palash Securities reports consolidated net loss of Rs 1.47 crore in the June 2026 quarter

NVCR Stock Gains After Novocure Announces Positive Topline Results In Metastatic Pancreatic Cancer Therapy Trial

Curbline Properties Director Alexander Otto Sells Over 231,000 Shares in Two-Day Transaction

Alexander Otto, a director at Curbline Properties Corp. (NYSE:CURB), sold a total of 231,943 common shares over two trading days, August 12 and 13, 2026. The sales were executed via his affiliated entity, KG Cura Vermogensverwaltung G.m.b.H. & Co., at weighted average prices of …

Ikarian Capital discloses 9.99% NextCure (NXTC) stake including large warrant position

Ikarian Capital, LLC and Neil Shahrestani have reported a beneficial ownership of 9.99% in NextCure, Inc. (NXTC), totaling 502,672 shares. This stake includes 449,369 shares that can be acquired within 60 days through warrants, which are subject to a 9.99% ownership cap. The calculation …

NextCure (NXTC) gains 15.8% beneficial owner in ADAR1 Capital and manager

ADAR1 Capital Management, LLC and its sole manager Daniel Schneeberger have reported a beneficial ownership of 15.8% of NextCure, Inc.'s common stock. This ownership, totaling 722,419 shares, is held by ADAR1-managed private funds and separately managed accounts, giving both ADAR1 and Schneeberger shared voting …

Insider Selling: Kratos Defense & Security Solutions (NASDAQ:KTOS) CEO Sells 300,000 Shares of Stock

Kratos Defense & Security Solutions (NASDAQ:KTOS) CEO Eric DeMarco sold 300,000 shares of the company's stock for approximately $19.3 million on August 14th. This transaction, conducted under a pre-arranged Rule 10b5-1 plan, reduced his direct ownership by 28.26%. The sale occurred after Kratos reported …

RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’

Atlanticus Holdings Corp (ATLC) Shares Surge 5.7% -- What GF Sco

Atlanticus Holdings Corp (ATLC) shares rose 5.7% to $102.53, with GuruFocus identifying the stock as 40.5% undervalued compared to its GF Value™ of $172.26. Despite a strong GF Score™ of 66/100 and high momentum, the company faces concerns regarding its low financial strength (2/10) …

Insider Selling: Cue Biopharma (NASDAQ:CUE) CEO Sells 18,258 Shares

Cue Biopharma CEO Shao-Lee Lin sold 18,258 shares of the company's stock for over $522,000 to cover tax withholding obligations from vested equity awards. This sale reduced her ownership by 2.52%, following a previous sale of 40,000 shares for $1.08 million. The company recently …

Cue Biopharma CEO Lin sells shares worth $1.6 million

Cue Biopharma CEO Lin Shao-Lee sold shares worth $1.6 million, primarily to cover tax obligations from vested restricted stock units, not as discretionary sales. Concurrently, Mr. Lin acquired 109,179 shares from vested performance stock units. The company has also appointed a new Chief Medical …

Insider plans 58,258-share stock sale (NASDAQ: CUE) under Rule 144

An insider of Cue Biopharma (NASDAQ: CUE) has filed a Rule 144 notice to sell up to 58,258 shares of common stock. These shares originated from restricted stock units that vested on August 1, 2026. The sale is planned to occur in two tranches …